These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 27184294)

  • 1. A novel "complement-metabolism-inflammasome axis" as a key regulator of immune cell effector function.
    Arbore G; Kemper C
    Eur J Immunol; 2016 Jul; 46(7):1563-73. PubMed ID: 27184294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging.
    Meyers AK; Zhu X
    Cells; 2020 Jul; 9(8):. PubMed ID: 32751530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct effects of complement and of NLRP3- and non-NLRP3 inflammasomes for choroidal neovascularization.
    Malsy J; Alvarado AC; Lamontagne JO; Strittmatter K; Marneros AG
    Elife; 2020 Dec; 9():. PubMed ID: 33305736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release.
    Laudisi F; Spreafico R; Evrard M; Hughes TR; Mandriani B; Kandasamy M; Morgan BP; Sivasankar B; Mortellaro A
    J Immunol; 2013 Aug; 191(3):1006-10. PubMed ID: 23817414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External Liver-Derived Complement and Intrinsic Present in Hematopoietic Stem/Progenitor Cells Complosome Modulate Cell Metabolism and Response to Stress.
    Thapa A; Ratajczak J; Kucia M; Ratajczak MZ
    Stem Cell Rev Rep; 2023 Jul; 19(5):1177-1184. PubMed ID: 36976465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.
    Niyonzima N; Bakke SS; Gregersen I; Holm S; Sandanger Ø; Orrem HL; Sporsheim B; Ryan L; Kong XY; Dahl TB; Skjelland M; Sørensen KK; Rokstad AM; Yndestad A; Latz E; Gullestad L; Andersen GØ; Damås JK; Aukrust P; Mollnes TE; Halvorsen B; Espevik T
    EBioMedicine; 2020 Oct; 60():102985. PubMed ID: 32927275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs: The key regulators in NLRP3 inflammasome-mediated inflammatory diseases.
    Feng X; Luo D; Wei G; Zhan F; Hua F; Xu G
    Int Immunopharmacol; 2021 Nov; 100():108105. PubMed ID: 34481143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-Trans Retinoic Acid Enhances both the Signaling for Priming and the Glycolysis for Activation of NLRP3 Inflammasome in Human Macrophage.
    Alatshan A; Kovács GE; Aladdin A; Czimmerer Z; Tar K; Benkő S
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes.
    Haggadone MD; Grailer JJ; Fattahi F; Zetoune FS; Ward PA
    Mediators Inflamm; 2016; 2016():1340156. PubMed ID: 27382187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myxoma virus lacking the pyrin-like protein M013 is sensed in human myeloid cells by both NLRP3 and multiple Toll-like receptors, which independently activate the inflammasome and NF-κB innate response pathways.
    Rahman MM; McFadden G
    J Virol; 2011 Dec; 85(23):12505-17. PubMed ID: 21957307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear Receptors in the Control of the NLRP3 Inflammasome Pathway.
    Duez H; Pourcet B
    Front Endocrinol (Lausanne); 2021; 12():630536. PubMed ID: 33716981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-Nlrp3 Inflammasome-Complement Cascade Axis in Sterile Brain Inflammation in Psychiatric Patients and its Impact on Stem Cell Trafficking.
    Ratajczak MZ; Mack A; Bujko K; Domingues A; Pedziwiatr D; Kucia M; Ratajczak J; Ulrich H; Kucharska-Mazur J; Samochowiec J
    Stem Cell Rev Rep; 2019 Aug; 15(4):497-505. PubMed ID: 31020518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement Component C5a Primes Retinal Pigment Epithelial Cells for Inflammasome Activation by Lipofuscin-mediated Photooxidative Damage.
    Brandstetter C; Holz FG; Krohne TU
    J Biol Chem; 2015 Dec; 290(52):31189-98. PubMed ID: 26565031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
    Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
    Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages.
    Yu S; Wang D; Huang L; Zhang Y; Luo R; Adah D; Tang Y; Zhao K; Lu B
    J Biol Chem; 2019 May; 294(21):8384-8394. PubMed ID: 30971430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POP1 inhibits MSU-induced inflammasome activation and ameliorates gout.
    de Almeida L; Devi S; Indramohan M; Huang QQ; Ratsimandresy RA; Pope RM; Dorfleutner A; Stehlik C
    Front Immunol; 2022; 13():912069. PubMed ID: 36225929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity.
    Li XX; Lee JD; Kemper C; Woodruff TM
    J Immunol; 2019 Jun; 202(12):3339-3348. PubMed ID: 31160390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRP3 Inflammasome and Its Critical Role in Gynecological Disorders and Obstetrical Complications.
    Fang X; Wang Y; Zhang Y; Li Y; Kwak-Kim J; Wu L
    Front Immunol; 2020; 11():555826. PubMed ID: 33584639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation.
    Lee AH; Shin HY; Park JH; Koo SY; Kim SM; Yang SH
    Sci Rep; 2021 Jan; 11(1):543. PubMed ID: 33436909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of NLRP3 inflammasome in inflammatory bowel diseases.
    Tourkochristou E; Aggeletopoulou I; Konstantakis C; Triantos C
    World J Gastroenterol; 2019 Sep; 25(33):4796-4804. PubMed ID: 31543674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.